A common landscape for membraneactive peptides

Protein Science

Volumn 22, Issue 7, 2013, Pages 870-882

  Last, Nicholas B ^a   Schlamadinger, Diana E ^a   Miranker, Andrew D ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

Amyloid; Antimicrobial peptides; Cell penetrating peptides; Lipid biophysics; Membrane protein folding

Indexed keywords

ALPHA SYNUCLEIN; AMYLIN; AMYLOID A PROTEIN; AMYLOID PRECURSOR PROTEIN; AMYLOID PROTEIN; CECROPIN A; CELL PENETRATING PEPTIDE; CHOLERA TOXIN B SUBUNIT; CYTOCHROME C'; LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDE; MAGAININ 2; PEPTIDE; PHOSPHATIDYLGLYCEROL; PROTEIN; AMYLOID; ANTIMICROBIAL CATIONIC PEPTIDE; MEMBRANE PROTEIN;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANTIMICROBIAL ACTIVITY; ATOMIC FORCE MICROSCOPY; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BRIGHT FIELD MICROSCOPY; CELL CULTURE; CELL MEMBRANE; CIRCULAR DICHROISM; COMBINATORIAL LIBRARY; CULTURE MEDIUM; CYTOTOXICITY; DISEASE COURSE; DNA SYNTHESIS; ENERGY; ENERGY RESOURCE; ENZYME ACTIVITY; EUKARYOTIC CELL; INFRARED SPECTROSCOPY; INTRACELLULAR SPACE; LANDSCAPE; LIPID BILAYER; LIPID MEMBRANE; MAMMAL CELL; MEMBRANE; MEMBRANE BINDING; MEMBRANE DAMAGE; MINIMUM INHIBITORY CONCENTRATION; MITOCHONDRIAL MEMBRANE; NEGATIVE FEEDBACK; NEUTRON SCATTERING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE; OLIGOMERIZATION; PANCREAS ISLET BETA CELL; PARKINSON DISEASE; PHOSPHOLIPID BILAYER; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; REVIEW; SCANNING TUNNELING MICROSCOPY; SOLID STATE; SURFACE TENSION; TRANSLATIONAL RESEARCH; X RAY DIFFRACTION; CHEMICAL STRUCTURE; HUMAN; METABOLISM;

AMYLOID; ANTIMICROBIAL CATIONIC PEPTIDES; CELL MEMBRANE; CELL-PENETRATING PEPTIDES; HUMANS; MEMBRANE PROTEINS; MODELS, MOLECULAR;

EID: 84881292325     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.2274     Document Type: Review

References (136)

1. Mim C, Cui H, Gawronski-Salerno JA, Frost A, Lyman E, Voth GA, Unger VM (2012) Structural basis of membrane bending by the N-BAR protein endophilin. Cell 149:137-145.
2. Jahn R, Fasshauer D (2012) Molecular machines governing exocytosis of synaptic vesicles. Nature 490: 201-207.
3. Milletti F (2012) Cell-penetrating peptides: classes, origin, and current landscape. Drug Discov Today 17: 850-860.
4. Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238-250.
5. Butterfield SM, Lashuel HA (2010) Amyloidogenic protein-membrane interactions: mechanistic insight from model systems. Angew Chem Int Ed Engl 49: 5628-5654.
6. Fuertes G, Gimenez D, Esteban-Martin S, Sanchez-Munoz OL, Salgado J (2011) A lipocentric view of peptide-induced pores. Eur Biophys J 40:399-415.
7. Wimley WC (2010) Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS Chem Biol 5:905-917.
8. Hebda JA, Miranker AD (2009) The interplay of catalysis and toxicity by amyloid intermediates on lipid bilayers: insights from type II diabetes. Annu Rev Biophys 38:125-152.
9. Vives E, Schmidt J, Pelegrin A (2008) Cell-penetrating and cell-targeting peptides in drug delivery. Biochim Biophys Acta 1786:126-138.
10. Durr UHN, Sudheendra US, Ramamoorthy A (2006) LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta 1758:1408-1425.
11. Morris MC, Depollier J, Mery J, Heitz F, Divita G (2001) A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol 19:1173-1176.
12. Snider C, Jayasinghe S, Hristova K, White SH (2009) MPEx: a tool for exploring membrane proteins. Protein Sci 18:2624-2628.
13. Williamson JA, Loria JP, Miranker AD (2009) Helix stabilization precedes aqueous and bilayer-catalyzed fiber formation in islet amyloid polypeptide. J Mol Biol 393:383-396.
14. Marion D, Zasloff M, Bax A (1988) A two-dimensional NMR study of the antimicrobial peptide magainin 2. FEBS Lett 227:21-26.
15. Maler L (2012) Solution NMR studies of cell-penetrating peptides in model membrane systems. Adv Drug Delivery Rev, http://dx.doi.org/10.1016/j.addr.2012. 10. 011.
16. Epand RM, Vogel HJ (1999) Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta 1462:11-28.
17. Jao CC, Hegde BG, Chen J, Haworth IS, Langen R (2008) Structure of membrane-bound a-synuclein from site-directed spin labeling and computational refinement. Proc Natl Acad Sci USA 105:19666-19671.
18. Huang HW (2006) Molecular mechanism of antimicrobial peptides: the origin of cooperativity. Biochim Biophys Acta 1758:1292-1302.
19. Bartels T, Choi JG, Selkoe DJ (2011) a-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477:107-110.
20. Marassi FM, Opella SJ, Juvvadi P, Merrifield RB (1999) Orientation of cecropin A helices in phospholipid bilayers determined by solid-state NMR spectroscopy. Biophys J 77:3152-3155.
21. Apostolidou M, Jayasinghe SA, Langen R (2008) Structure of a-helical membrane-bound human islet amyloid polypeptide and its implications for membrane-mediated misfolding. J Biol Chem 283: 17205-17210.
22. Ding B, Chen Z (2012) Molecular interactions between cell penetrating peptide Pep-1 and model cell membranes. J Phys Chem B 116:2545-2552.
23. Trexler AJ, Rhoades E (2009) a-synuclein binds large unilamellar vesicles as an extended helix. Biochemistry 48:2304-2306.
24. Ferreon ACM, Gambin Y, Lemke EA, Deniz AA (2009) Interplay of a-synuclein binding and conformational switching probed by single-molecule fluorescence. Proc Natl Acad Sci USA 106:5645-5650.
25. Bleicken S, Classen M, Padmavathi PVL, Ishikawa T, Zeth K, Steinhoff H-J, Bordignon E (2010) Molecular details of bax activation, oligomerization, and membrane insertion. J Biol Chem 285:6636-6647.
26. Knight JD, Hebda JA, Miranker AD (2006) Conserved and cooperative assembly of membrane-bound a-helical states of islet amyloid polypeptide. Biochemistry 45:9496-9508.
27. Wieprecht T, Dathe M, Schumann M, Krause E, Beyermann M, Bienert M (1996) Conformational and functional study of magainin 2 in model membrane environments using the new approach of systematic double-D-amino acid replacement. Biochemistry 35: 10844-10853.
28. Eirksdottir E, Konate K, Langel U, Divita G, Deshayes S (2010) Secondary structure of cell-penetrating peptides controls membrane interaction and insertion. Biochim Biophys Acta 1798:1119-1128.
29. Quist A, Doudevski L, Lin H, Azimova R, Ng D, Frangione B, Kagan B, Ghiso J, Lal R (2005) Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci USA 102:10427-10432.
30. Schauerte JA, Wong PT, Wisser KC, Ding H, Steel DG, Gafni A (2010) Simultaneous single-molecule fluorescence and conductivity studies reveal distinct classes of Ab species on lipid bilayers. Biochemistry 49: 3031-3039.
31. Magzoub M, Miranker AD (2012) Concentration-dependent transitions govern the subcellular localization of islet amyloid polypeptide. FASEB J 26:1228-1238.
32. He K, Ludtke SJ, Worcester DL, Huang HW (1996) Neutron scattering in the plane of membranes: structure of alamethicin pores. Biophys J 70:2659-2666.
33. Qian S, Wang W, Yang L, Huang HW (2008) Structure of the alamethicin pore reconstructed by x-ray diffraction analysis. Biophys J 94:3512-3522.
34. Nath A, Miranker AD, Rhoades E (2011) A membrane-bound antiparallel dimer of rat islet amyloid polypeptide. Angew Chem Int Ed 50:10859-10862.
35. Last NB, Rhoades E, Miranker AD (2011) Islet amyloid polypeptide demonstrates a persistent capacity to disrupt membrane integrity. Proc Natl Acad Sci USA 108:9460-9465.
36. Gregory SM, Cavenaugh A, Journigan V, Pokorny A, Almeida PFF (2008) A quantitative model for the allor-none permeabilization of phospholipid vesicles by the antimicrobial peptide cecropin A. Biophys J 94: 1667-1680.
37. Yandek LE, Pokorny A, Floren A, Knoelke K, Langel U, Almeida PFF (2007) Mechanism of the cell-penetrating peptide transportan 10 permeation of lipid bilayers. Biophys J 92:2434-2444.
38. Lin H, Bhatia R, Lal R (2001) Amyloid b protein forms ion channels: implications for Alzheimer's disease pathophysiology. FASEB J 15:2433-2444.
39. Mirzabekov TA, Lin M-C, Kagan BL (1996) Pore formation by the cytotoxic islet amyloid peptide amylin. J Biol Chem 271:1988-1992.
40. Sokolov Y, Mirzabekov T, Martin DW, Lehrer RI, Kagan BL (1999) Membrane channel formation by antimicrobial protegrins. Biochim Biophys Acta 1420: 23-29.
41. Capone R, Mustata M, Jang H, Arce FT, Nussinov R, Lal R (2010) Antimicrobial protegrin-1 forms ion channels: molecular dynamic simulation, atomic force microscopy, and electrical conductance studies. Biophys J 98:2644-2652.
42. Brender JR, Hartman K, Reid KR, Kennedy RT, Ramamoorthy A (2008) A single mutation in the nonamyloidogenic region of islet amyloid polypeptide greatly reduces toxicity. Biochemistry 47:12680-12688.
43. Garwood CJ, Pooler AM, Atherton J, Hanger DP, Noble W (2011) Astrocytes are important mediators of Ab-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis 2:e167.
44. Guillemin Y, Lopez J, Gimenez D, Fuertes G, Valero JG, Blum L, Gonzalo P, Salgado J, Girard-Egrot A, Aouacheria A (2010) Active fragments from pro-and antiapoptotic BCL-2 proteins have distinct membrane behavior reflecting their functional divergence. PLoS One 5:e9066.
45. Ryser HJ-P, Hancock R (1965) Histones and basic polyamino acids stimulate the uptake of albumin by tumor cells in culture. Science 150:501-503.
46. Matsuzaki K (2009) Control of cell selectivity of antimicrobial peptides. Biochim Biophys Acta 1788: 1687-1692.
47. Magzoub M, Eriksson LEG, Graslund A (2002) Conformational states of the cell-penetrating peptide penetratin when interacting with phospholipid vesicles: effects of surface charge and peptide concentration. Biochim Biophys Acta 1563:53-63.
48. Magzoub M, Graslund A (2004) Cell-penetrating peptides: small from inception to application. Q Rev Biophys 37:147-195.
49. Rustenbeck I, Matthies A, Lenzen S (1994) Lipid composition of glucose-stimulated pancreatic islets and insulin-secreting tumor cells. Lipids 29:685-692.
50. Sunde M, Blake CC (1998) From the globular to the fibrous state: protein structure and structural conversion in amyloid formation. Q Rev Biophys 31:1-39.
51. Barnhart MM, Chapman MR (2006) Curli biogenesis and function. Annu Rev Microbiol 60:131-147.
52. Maji SK, Perrin MH, Sawaya MR, Jessberger S, Vadodaria K, Rissman RA, Singru PS, Nilsson KPR, Simon R, Schubert D, Eisenberg D, Rivier J, Sawchenko P, Vale W, Riek R (2009) Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 325:328-332..
53. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL (1999) Soluble pool of Ab amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol 46:860-866.
54. Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC (1999) The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 48:491-498.
55. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486-489.
56. Bokvist M, Lindstrom F, Watts A, Grobner G (2004) Two types of Alzheimer's b-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation. J Mol Biol 335:1039-1049.
57. Ji S-R, Wu Y, Sui S-F (2002) Cholesterol is an important factor affecting the membrane insertion of bamyloid peptide (Ab 1-40), which may potentially inhibit the fibril formation. J Biol Chem 277:6273-6279.
58. Zakharov SD, Hulleman JD, Dutseva EA, Antonenko YN, Rochet J-C, Cramer WA (2007) Helical a-synuclein forms highly conductive ion channels. Biochemistry 46:14369-14379.
59. Knight JD, Miranker AD (2004) Phospholipid catalysis of diabetic amyloid assembly. J Mol Biol 341: 1175-1187.
60. Shvadchak VV, Falomir-Lockhart LJ, Yushchenko DA, Jovin TM (2011) Specificity and kinetics of a-synuclein binding to model membranes determined with fluorescent excited state intramolecular proton transfer (ESIPT) probe. J Biol Chem 286:13023-13032.
61. Terzi E, Holzemann G, Seelig J (1997) Interaction of Alzheimer b-amyloid peptide(1-40) with lipid membranes. Biochemistry 36:14845-14852.
62. Nerelius C, Sandegren A, Sargsyan H, Raunak R, Leijonmarck H, Chatterjee U, Fisahn A, Imarisio S, Lomas DA, Crowther DC, Stromberg R, Johansson J (2009) a-helix targeting reduces amyloid-b peptide toxicity. Proc Natl Acad Sci USA 106:9191-9196.
63. Hebda JA, Saraogi I, Magzoub M, Hamilton AD, Miranker AD (2009) A peptidomimetic approach to targeting pre-amyloidogenic states in type II diabetes. Chem Biol 16:943-950.
64. Laganowsky A, Liu C, Sawaya MR, Whitelegge JP, Park J, Zhao M, Pensalfini A, Soriaga AB, Landau M, Teng PK, Cascio D, Glabe C, Eisenberg D (2012) Atomic view of a toxic amyloid small oligomer. Science 335:1228-1231.
65. Tian A, Baumgart T (2009) Sorting of lipids and proteins in membrane curvature gradients. Biophys J 96: 2676-2688.
66. Smith PES, Brender JR, Ramamoorthy A (2009) Induction of negative curvature as a mechanism of cell toxicity by amyloidogenic peptides: the case of islet amyloid polypeptide. J Am Chem Soc 131: 4470-4478.
67. Matsuzaki K, Horikiri C (1999) Interactions of amyloid b-peptide (1-40) with ganglioside-containing membranes. Biochemistry 38:4137-4142.
68. Middleton ER, Rhoades E (2010) Effects of curvature and composition on a-synuclein binding to lipid vesicles. Biophys J 99:2279-2288.
69. Last NB, Miranker AD (2013) Common mechanism unites membrane poration by amyloid and antimicrobial peptides. Proc Natl Acad Sci USA 110: 6382-6387.
70. Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD (2010) The Alzheimer's disease-associated amyloid b-protein is an antimicrobial peptide. PLoS One 5:e9505.
71. Wang L, Liu Q, Chen J-C, Cui Y-X, Zhou B, Chen YX, Zhao Y-F, Li Y-M (2012) Antimicrobial activity of human islet amyloid polypeptides: an insight into amyloid peptides' connection with antimicrobial peptides. Biol Chem 393:641-646.
72. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389-395.
73. Nakatsuji T, Gallo RL (2011) Antimicrobial peptides: old molecules with new ideas. J Invest Dermatol 132: 887-895.
74. Nguyen LT, Haney EF, Vogel HJ (2011) The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol 29:464-472.
75. Bechinger B (1997) Structure and functions of channel-forming peptides: magainins, cecropins, melittin and alamethicin. J Membr Biol 156:197-211.
76. Epand RM, Epand RF (2010) Bacterial membrane lipids in the action of antimicrobial agents. J Peptide Sci 17:298-305.
77. Zelezetsky I, Tossi A (2006) Alpha-helical antimicrobial peptides-using a sequence template to guide structure-activity relationship studies. Biochim Biophys Acta 1758:1436-1449.
78. Dathe M, Nikolenko H, Meyer J, Beyermann M, Bienert M (2001) Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS Lett 501:146-150.
79. Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS (2007) Role of peptide hydrophobicity in the mechanism of action of a-helical antimicrobial peptides. Antimicrob Agents Chemother 51:1398-1406.
80. Yin LM, Edwards MA, Li J, Yip CM, Deber CM (2012) Roles of hydrophobicity and charge distribution of cationic antimicrobial peptides in peptide-membrane interactions. J Biol Chem 287:7738-7745.
81. Chen Y, Mant CT, Farmer SW, Hancock REW, Vasil ML, Hodges RS (2005) Rational design of a-helical antimicrobial peptides with enhanced activities and specificity/ therapeutic index. J Biol Chem 280:12316-12329.
82. Nicolas P (2009) Multifunctional host defense peptides: intracellular-targeting antimicrobial peptides. FEBS J 276:6483-6496.
83. Gazit E, Boman A, Boman HG, Shai Y (1995) Interaction of the mammalian antibacterial peptide cecropin P1 with phospholipid vesicles. Biochemistry 34: 11479-11488.
84. Pouny Y, Rapaport D, Mor A, Nicolas P, Shai Y (1992) Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. Biochemistry 31:12416-12423.
85. Ludtke SJ, He K, Heller WT, Harroun TA, Yang L, Huang HW (1996) Membrane pores induced by magainin. Biochemistry 35:13723-13728.
86. Yamaguchi S, Hong T, Waring A, Lehrer RI, Hong M (2002) Solid-state NMR investigations of peptide-lipid interaction and orientation of a beta-sheet antimicrobial peptide, protegrin. Biochemistry 41:9852-9862.
87. Pieta P, Mirza J, Lipkowski J (2012) Direct visualization of the alamethicin pore formed in a planar phospholipid matrix. Proc Natl Acad Sci USA 109: 21223-21227.
88. Gregory SM, Pokorny A, Almeida PFF (2009) Magainin 2 revisited: a test of the quantitative model for the all-or-none permeabilization of phospholipid vesicles. Biophys J 96:116-131.
89. Lee M-T, Chen F-Y, Huang HW (2004) Energetics of pore formation induced by membrane active peptides. Biochemistry 43:3590-3599.
90. Naito A, Nagao T, Norisada K, Mizuno T, Tuzi S, Saito H (2000) Conformation and dynamics of melittin bound to magnetically oriented lipid bilayers by solidstate (31)P and (13)C NMR spectroscopy. Biophys J 78:2405-2417.
91. Ladokhin AS, White SH (2001) 'Detergent-like' permeabilization of anionic lipid vesicles by melittin. Biochem Biophys Acta 1514:253-260.
92. Vogel H, Jahnig F (1986) The structure of melittin in membranes. Biophys J 50:573-582.
93. Krauson AJ, He J, Wimley WC (2012) Determining the mechanism of membrane permeabilizing peptides: identification of potent, equilibrium pore-formers. Biochim Biophys Acta 1818:1625-1632.
94. Dumont ME, Richards FM (1984) Insertion of apocytochrome c into lipid vesicles. J Biol Chem 259: 4147-4156.
95. van den Berg A, Dowdy SF (2011) Protein transduction domain delivery of therapeutic macromolecules. Curr Opin Biotechnol 22:888-893.
96. McNaughton BR, Cronican JJ, Thompson DB, Liu DR (2009) Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins. Proc Natl Acad Sci USA 106:6111-6116.
97. Andreev OA, Karabadzhak AG, Weerakkody D, Andreev GO, Engelman DM, Reshetnyak YK (2010) pH (low) insertion peptide (pHLIP) inserts across a lipid bilayer as a helix and exits by a different path. Proc Natl Acad Sci USA 107:4081-4086.
98. Marks JR, Placone J, Hristova K, Wimley WC (2011) Spontaneous membrane-translocating peptides by orthogonal high-throughput screening. J Am Chem Soc 133:8995-9004.
99. Splith K, Neundorf I (2011) Antimicrobial peptides with cell-penetrating peptide properties and vice versa. Eur Biophys J 40:387-397.
100. Sandgren S, Wittrup A, Cheng F, Jonsson M, Eklund E, Busch S, Belting M (2004) The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J Biol Chem 279:17951-17956.
101. Pokorny A, Birkbeck TH, Almeida PFF (2002) Mechanism and kinetics of d-lysin interaction with phospholipid vesicles. Biochemistry 41:11044-11056.
102. Anguiano M, Nowak RJ, Lansbury PT Jr (2002) Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes. Biochemistry 41: 11338-11343.
103. Shai Y (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by a-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1462:55-70.
104. Matsuzaki K (1999) Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim Biophys Acta 1462:1-10.
105. Huang HW (2000) Action of antimicrobial peptides: two-state model. Biochemistry 39:8347-8352.
106. Huang HW, Chen F-Y, Lee M-T (2004) Molecular mechanism of peptide-induced pores in membranes. Phys Rev Lett 92:198304.
107. Chen F-Y, Lee M-T, Huang HW (2003) Evidence for membrane thinning effect as the mechanism for peptide-induced pore formation. Biophys J 84:3751-3758.
108. Polozov IV, Anantharamaiah GM, Segrest JP, Epand RM (2001) Osmotically induced membrane tension modulates membrane permeabilization by class L amphipathic helical peptides: nucleation model of defect formation. Biophys J 81:949-959.
109. Litster JD (1975) Stability of lipid bilayers and red blood cell membranes. Phys Lett A 53:193-194.
110. Taupin C, Dvolaitzky M, Sauterey C (1975) Osmotic pressure induced pores in phospholipid vesicles. Biochemistry 14:4771-4775.
111. Puech P-H, Borghi N, Karatekin E, Brochard-Wyart F (2003) Line thermodynamics: adsorption at a membrane edge. Phys Rev Lett 90:128304.
112. Matsuzaki K, Sugishita K, Ishibe N, Ueha M, Nakata S, Miyajima K, Epand RM (1998) Relationship of membrane curvature to the formation of pores by magainin 2. Biochemistry 37:11856-11863.
113. Henzler Wildman KA, Lee D-K, Ramamoorthy A (2003) Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. Biochemistry 42: 6545-6558.
114. Mishra A, Lai GH, Schmidt NW, Sun VZ, Rodriguez AR, Tong R, Tang L, Cheng J, Deming TJ, Kamei DT, Wong GCL (2011) Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions. Proc Natl Acad Sci USA 108:16883-16888.
115. Chen F-Y, Lee M-T, Huang HW (2002) Sigmoidal concentration dependence of antimicrobial peptide activities: a case study on alamethicin. Biophys J 82: 908-914.
116. Tamba Y, Ariyama H, Levadny V, Yamazaki M (2010) Kinetic pathway of antimicrobial peptide magainin 2-induced pore formation in lipid membranes. J Phys Chem B 114:12018-12026.
117. Fuertes G, Garcia-Saez AJ, Esteban-Martin S, Gimenez D, Sanchez-Munoz OL, Schwille P, Salgado J (2010) Pores formed by Baxa5 relax to a smaller size and keep at equilibrium. Biophys J 99:2917-2925.
118. Lee M-T, Hung W-C, Chen F-Y, Huang HW (2008) Mechanism and kinetics of pore formation in membranes by water-soluble amphipathic peptides. Proc Natl Acad Sci USA 105:5087-5092.
119. Jang H, Arce FT, Mustata M, Ramachandran S, Capone R, Nussinov R, Lal R (2011) Antimicrobial protegrin-1 forms amyloid-like fibrils with rapid kinetics suggesting a functional link. Biophys J 100:1775-1783.
120. Sood R, Domanov Y, Pietiainen M, Kontinen VP, Kinnunen PKJ (2008) Binding of LL-37 to model biomembranes: insight into target vs host cell recognition. Biochim Biophys Acta 1778:983-996.
121. Choo-Smith L-P, Garzon-Rodriguez W, Glabe CG, Surewicz WK (1997) Acceleration of amyloid fibril formation by specific binding of Ab-(1-40) peptide to ganglioside-containing membrane vesicles. J Biol Chem 272:22987-22990.
122. Zhu M, Li J, Fink AL (2003) The association of a-synuclein with membranes affects bilayer structure, stability, and fibril formation. J Biol Chem 278: 40186-40197.
123. Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK (2008) Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 283: 9089-9100.
124. Anandatheerthavarada HK, Biswas G, Robin M-A, Avadhani NG (2003) Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol 161:41-54.
125. Du H, Guo L, Yan S, Sosunov AA, McKhann GM, Yan SS (2010) Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proc Natl Acad Sci USA 107:18670-18675.
126. Gurlo T, Ryazantsev S, Huang C-J, Yeh MW, Reber HA, Hines OJ, O'Brien TD, Glabe CG, Butler PC (2010) Evidence for proteotoxicity in b cells in type 2 diabetes. Am J Pathol 176:861-869.
127. Zhang X, OgleRcka K, Sandgren S, Belting M, Esbjorner EK, Norden B, Graslund A (2010) Dual functions of the human antimicrobial peptide LL-37-target membrane perturbation and host cell cargo delivery. Biochim Biophys Acta 1798:2201-2208.
128. Kobayashi S, Chikushi A, Tougu S, Imura Y, Nishida M, Yano Y, Matsuzaki K (2004) Membrane translocation mechanism of the antimicrobial peptide buforin 2. Biochemistry 43:15610-15616.
129. Takeshima K, Chikushi A, Lee K-K, Yonehara S, Matsuzaki K (2003) Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes. J Biol Chem 278:1310-1315.
130. Park CB, Yi K-S, Matsuzaki K, Kim MS, Kim SC (2000) Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. Proc Natl Acad Sci USA 97:8245-8250.
131. Nekhotiaeva N, Elmquist A, Rajarao GK, Hallbrink M, Langel U, Good L (2004) Cell entry and antimicrobial properties of eukaryotic cell-penetrating peptides. FASEB J 18:394-396.
132. Palm C, Netzereab S, Hallbrink M (2006) Quantitatively determined uptake of cell-penetrating peptides in non-mammalian cells with an evaluation of degradation and antimicrobial effects. Peptides 27: 1710-1716.
133. Kilk K, Mahlapuu R, Soomets U, Langel U (2009) Analysis of in vitro toxicity of five cell-penetrating peptides by metabolic profiling. Toxicology 265:87-95.
134. Saar K, Lindgren M, Hansen M, Eirksdottir E, Jiang Y, Rosenthal-Aizman K, Sassian M, Langel U (2005) Cell-penetrating peptides: a comparative membrane toxicity study. Anal Biochem 345:55-65.
135. Jones SW, Christison R, Bundell K, Voyce CJ, Brockbank SMV, Newham P, Lindsay MA (2005) Characterisation of cell-penetrating peptide-mediated peptide delivery. Br J Pharmacol 145:1093-1102.
136. Herce HD, Garcia AE, Litt J, Kane RS, Martin P, Enrique N, Rebolledo A, Milesi V (2009) Arginine-rich peptides destabilize the plasma membrane, consistent with a pore formation translocation mechanism of cell-penetrating peptides. Biophys J 97:1917-1925.